Vycellix, Inc., an immuno-centric discovery life science company with a focus on natural killer cell-based (NK cell) therapeutics, today announced that members of its executive leadership team are scheduled to present and moderate panel sessions at the following upcoming life science conferences this week.
Our News
We’re on a mission to start a conversation with your customers in this fast connected world.